Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

From the fundamentals of multiple sclerosis to clinical management.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Patient and Physician Perspectives on MSdialog, an Electronic PRO Diary in Multiple Sclerosis.
Multisystem involvement in neuromyelitis optica.
Detection of aquaporin-4 antibody using aquaporin-4 extracellular loop-based carbon nanotube biosensor for the diagnosis of neuromyelitis optica.
Purinergic Signaling and the Functioning of the Nervous System Cells.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Vitamin d3 concentration correlates with the severity of multiple sclerosis.
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.

Pages